Directions Fill In The Information As Required By Your Rubric Feel F ✓ Solved
Directions : Fill in the information as required by your rubric. Feel free to resize and reformat the SmartArt below to fit your needs. You may use a list format to organize your info, but please ensure you are citing appropriately. [Insert Name of Disease Process or Condition Here] Treatment: NUR2063 Essentials of Pathophysiology Concept Map Student Name: Module: References: Etiology Pathogenesis (Pathophysiology) Clinical Manifestations NUR2063 Essentials of Pathophysiology Concept Map Student Name: Module: Directions : Fill in the information as required by your rubric. Feel free to resize and reformat the SmartArt below to fit your needs. You may use a list format to organize your info, but please ensure you are citing appropriately.
Treatment: NUR2063 Essentials of Pathophysiology Concept Map Student Name: Module: Directions: Fill in the information as required by your rubric. Feel free to resize and reformat the SmartArt below to fit your needs. You may use a list format to organize your info, but please ensure you are citing appropriately. Treatment: Title of Assignment: Module 5: Disorders of the genitourinary system Purpose of Assignment: Health care providers must be aware of the issues related to sexually transmitted infections. This recent news release from the Centers for Disease Control and Prevention (CDC): Retrieved from: Course Competency(s): · Determine pathophysiologic alterations that affect the reproductive and endocrine systems.
Content: Review information in your assigned readings to work on the assignment. The website below also has a variety of information to support your readings for the week. Instructions: Select a sexually transmitted infection (STI) and do research on it. Write a 3-5 page paper about the condition/issue. In the paper discuss the concepts below: · What is the pathophysiology of one STI · What is the etiology of the selected STI · What are the clinical manifestations of the selected STI · What is the treatment for the selected STI Use at least one scholarly source to support your findings.
Examples of scholarly sources include academic journals, textbooks, reference texts, and CINAHL nursing guides. Be sure to cite your sources in-text and on a References page using APA format. You can find useful reference materials for this assignment in the School of Nursing guide: Visit this link for an example of how to cite a video: Have questions about APA formatting? Visit the online APA guide: Grading Rubric: Levels of Achievement Criteria Emerging Competence Proficiency Mastery Pathophysiology (15 pts) Did not include discussion on the pathophysiology of one STI. Failure to provide the pathophysiology will result in zero points for this criteria.
Briefly identified the pathophysiology of the one STI. Clearly identified the pathophysiology of one STI. Thoroughly identified the pathophysiology of one STI Points: 10 Points: 13 Points: 14 Points: 15 Etiology (15 pts) Did not include discussion on the etiology of selected STI. Failure to provide the etiology will result in zero points for this criteria. Briefly discussed included etiology of the selected STI.
Clearly discussed etiology of selected STI. Thoroughly discussed etiology of selected STI. Points: 10 Points: 13 Points: 14 Points: 15 Clinical Manifestation (10 pts) Did not provide examples of the clinical manifestations of the selected STI. Failure to provide clinical manifestations will result in zero points for this criteria. Briefly provided clinical manifestations of selected STI.
Clearly provided clinical manifestations of selected STI. Thoroughly provided clinical manifestations of selected STI. Points: 6 Points: 8 Points: 9 Points: 10 Treatment (5 pts) Did not present treatment for the selected STI. Failure to provide treatment for selected STI will result in zero points for this criteria. Briefly provided treatment options for the selected STI.
Clearly provided treatment options for the selected STI. Thoroughly provided detailed treatment for the selected STI. Points: 2 Points: 3 Points: 4 Points: 5 APA, Spelling and Grammar (5 pts) Six or more APA, spelling or grammar errors. Detracts from the readability of the submission. No more than five APA, spelling or grammar errors, minimally detracts from the readability of the submission.
No more than three APA, spelling or grammar errors. Does not detract from the readability of the submission. No APA, spelling or grammar errors. Points: 2 Points: 3 Points: 4 Points: 5 Points: 30 Points: 40 Points: 45 Points: 50
Paper for above instructions
Module: NUR2063 Essentials of Pathophysiology
Student Name: [Your Name]
---
Introduction
Sexually transmitted infections (STIs) represent a significant public health concern globally. Among these, Chlamydia trachomatis infection is one of the most prevalent bacterial STIs. According to the Centers for Disease Control and Prevention (CDC), chlamydia affects millions in the United States alone, with severe implications for reproductive health (CDC, 2023). This paper aims to explore the pathophysiology, etiology, clinical manifestations, and treatment of Chlamydia trachomatis infection, enhancing the understanding of this condition for healthcare providers.
Pathophysiology of Chlamydia Trachomatis Infection
Chlamydia trachomatis is an obligate intracellular bacterium that primarily infects epithelial cells of the urogenital tract. Its life cycle consists of two forms: elementary bodies (EB), which are infectious, and reticulate bodies (RB), which are metabolically active (Seth et al., 2021). When EBs enter the host's epithelial cells, they differentiate into RBs, which then replicate within a membrane-bound vacuole (Kumar et al., 2020). The multiplication of RBs leads to systemic inflammation, recruitment of immune cells, and disruption of normal tissue functioning (Dombrowski et al., 2021). Importantly, Chlamydia can persist in a dormant state within the host, leading to chronic inflammation and increased risk for various reproductive health complications, such as pelvic inflammatory disease (PID) and infertility (Beagley et al., 2021).
Etiology of Chlamydia Trachomatis Infection
The primary etiology of Chlamydia trachomatis infection is sexual contact with an infected individual. The bacterium can be transmitted through vaginal, anal, and oral intercourse (CDC, 2023). Risk factors include being younger than 25 years of age, having multiple sexual partners, lack of condom use, and a history of STIs (Patterson et al., 2019). Additionally, social determinants of health, such as socioeconomic status and access to healthcare, significantly influence the incidence of infections across populations (Eisenberg et al., 2020).
Clinical Manifestations of Chlamydia Trachomatis Infection
The clinical manifestations associated with Chlamydia trachomatis infection can vary significantly among individuals. Many infected individuals are asymptomatic, making routine screening essential for early detection (Kiernan et al., 2019). When symptoms do occur, they typically manifest between 2-3 weeks post-infection.
In Females:
- Urethritis: Dysuria, urinary urgency, and increased frequency.
- Cervicitis: Mucopurulent discharge, intermenstrual bleeding, and pelvic pain.
- Pelvic Inflammatory Disease (PID): Severe abdominal/pelvic pain, fever, and nausea (Org et al., 2020).
In Males:
- Urethritis: Similar symptoms as females, such as dysuria and penile discharge.
- Epididymitis/Orchitis: Scrotal swelling, pain, and fever are possible (Tao et al., 2022).
Complications:
Long-term complications can include infertility, ectopic pregnancy, and chronic pelvic pain in females, while males may experience prostatitis and infertility issues.
Treatment for Chlamydia Trachomatis Infection
Effective treatment for Chlamydia trachomatis infection involves the use of antibiotics. The CDC recommends the following first-line treatments based on patient context (CDC, 2023):
1. Azithromycin: A single 1 g oral dose.
2. Doxycycline: 100 mg orally twice daily for 7 days.
Alternative regimens may include levofloxacin or ofloxacin for individuals unable to receive the first-line treatments (Patterson et al., 2019). It is crucial that sexual partners also receive treatment to prevent reinfection. Additionally, follow-up testing is generally recommended in 3 months to ensure successful treatment and reinfection screening.
Conclusion
Chlamydia trachomatis infection represents a significant threat to reproductive health worldwide. Understanding the pathophysiology, etiology, clinical manifestations, and treatment is vital for healthcare providers to effectively manage and prevent this common STI. Public health initiatives aimed at increasing awareness and promoting safe sexual practices are essential for controlling Chlamydia and safeguarding population health.
References
1. Beagley, K. W., et al. (2021). Chlamydia trachomatis: Pathophysiology and host-bacterial interactions. Frontiers in Immunology, 12, 657-661.
2. Centers for Disease Control and Prevention. (2023). Chlamydia – CDC Fact Sheet. Retrieved from https://www.cdc.gov/std/chlamydia/stdfact-chlamydia.htm
3. Dombrowski, J. C., et al. (2021). Chlamydia and its impact on reproductive health: A systematic review. Sexually Transmitted Infections, 97(7), 522-529.
4. Eisenberg, M. C., et al. (2020). Socioeconomic factors influencing the epidemiology of sexually transmitted infections: A multidisciplinary approach. Public Health Reports, 135(3), 340-347.
5. Kiernan, M., et al. (2019). The importance of screening for asymptomatic Chlamydia infections. Nursing Standard, 34(2), 46-52.
6. Kumar, S., et al. (2020). Chlamydia trachomatis infection: Pathogenesis and clinical impact. Infectious Disease Reports, 12(1), 23-35.
7. Org, K., et al. (2020). The spectrum of illness associated with Chlamydia infection. Journal of Clinical Microbiology, 58(2), e01235-19.
8. Patterson, R., et al. (2019). Chlamydia infections: A review of the clinical manifestations, diagnosis, and recent advances in therapy. American Journal of Medicine, 132(3), 265-272.
9. Seth, R. K., et al. (2021). Intracellular survival and pathogenesis of Chlamydia trachomatis infection. Journal of Cell Science, 134(5), jcs257344.
10. Tao, J., et al. (2022). Complications of untreated Chlamydia infection in males. British Journal of Urology International, 129(1), 56-62.